PET screening of anticancer drugs. A faster route to drug/target evaluations in vivo

Methods Mol Med. 2003:85:279-94. doi: 10.1385/1-59259-380-1:279.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Drug Evaluation / methods*
  • Drug Screening Assays, Antitumor / methods*
  • Enzyme Inhibitors / pharmacology
  • ErbB Receptors / antagonists & inhibitors
  • Haplorhini
  • Humans
  • Image Processing, Computer-Assisted
  • Isotope Labeling / methods
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasms / diagnostic imaging
  • Neoplasms / drug therapy*
  • Neoplasms, Experimental / diagnostic imaging
  • Neoplasms, Experimental / drug therapy*
  • Quinazolines / pharmacology
  • Radiopharmaceuticals
  • Rats
  • Tomography, Emission-Computed* / veterinary
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Neoplasm Proteins
  • Quinazolines
  • Radiopharmaceuticals
  • ErbB Receptors
  • 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline